The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Consolidated loss | -8,249,343 |
| Depreciation, accretion and amortization, net | 877,675 |
| Loss (gain) on sale of assets | -183 |
| Provision for credit losses | 62,958 |
| Provision for inventory reserve | 110,488 |
| Unrealized gain on marketable securities | 10,993 |
| Gain on the sale of marketable securities | 3,687 |
| Stock-based compensation | 348,029 |
| Goodwill and long-lived asset impairment | 1,113,129 |
| Non-cash interest expense | 43,476 |
| Accounts receivable | -1,682,596 |
| Inventory, net | 1,426,182 |
| Unbilled revenue | 260,879 |
| Prepaid assets and other current assets | 405,745 |
| Other non-current assets | -464,576 |
| Accounts payable | -761,131 |
| Accrued expenses | -76,736 |
| Deferred revenue | -3,070,219 |
| Other current liabilities | -871,627 |
| Net cash provided by (used in) operating activities | -9,911,674 |
| Purchases of property and equipment | 400,781 |
| Proceeds on sale of property and equipment | 4,290 |
| Distributions to noncontrolling interest | 67,639 |
| Net used in investing activities | -464,130 |
| Proceeds from follow-on offering, net of transaction costs | 18,105,100 |
| (repayment of) proceeds from related party note | -1,076,956 |
| Finance lease principal payments | 324,065 |
| Proceeds from exercise of stock options | 696,779 |
| Net cash provided by financing activities | 17,400,858 |
| Change in cash and cash equivalents | 7,025,054 |
| Cash and cash equivalents, beginning of the year | 5,405,233 |
| Cash and cash equivalents, end of the year | 12,430,287 |
TECOGEN INC. (TGEN)
TECOGEN INC. (TGEN)